Lucid Diligence Brief - BioPharma

GNI Group Acquires Ayumi Pharmaceutical | Lucid Diligence Brief

GNI Group’s Ayumi acquisition tests Japan commercial scale, Calonal durability,…


Lucid Diligence Brief - BioPharma

Vida Health and Instacart Health Partner on Fresh Funds | Lucid Diligence Brief

Vida Health’s Instacart Health partnership tests whether grocery stipends can…


Lucid Diligence Brief - BioPharma

Haisco Lilly Collaboration | Lucid Diligence Brief

Haisco’s Lilly Deal Tests China-Originated Small-Molecule Discovery…


Lucid Diligence Brief - BioPharma

Secretome STM-01 Duchenne Cardiomyopathy | Lucid Diligence Brief

Secretome’s STM-01 faces Duchenne cardiomyopathy endpoint, CMC, and regulatory…


Lucid Diligence Brief - Tech

Lucid Diligence Brief: Unio Health Partners and Thesis Care partnership

Lucid Diligence Brief: Unio Health Partners and Thesis Care’s AI clinical teams…


Lucid Diligence Brief - Tech

Lucid Diligence Brief: Insilico and Human Longevity collaboration

Lucid Diligence Brief: Insilico Medicine and Human Longevity collaborate on AI…


Lucid Diligence Brief - Tech

Lucid Diligence Brief: Polyphonic Intelligent OR Network Launched by J&J for AI-Powered Surgery

Lucid Diligence Brief: Polyphonic Intelligent OR Network by J&J uses AI to…


Lucid Diligence Brief - BioPharma

Lucid Diligence Brief: Endologix's Pounce Acquisition

Lucid Diligence Brief: Endologix’s Pounce acquisition framed through clinical,…


Lucid Diligence Brief - BioPharma

Lucid Diligence Brief: Iterative Health Acquisition of NextStage Cardiology Research Sites

Lucid Diligence Brief: Iterative Health Acquisition of NextStage Cardiology…


How Education can serve as a catalyst for wider Biosimilar Adoption.

Even two decades after their introduction, the global adoption rate of…


Digital vaccines against lifestyle diseases

Can "Digital Vaccines" be a game-changer in lifestyle diseases?

Digital vaccines are clinically proven  "no injection, no ingestion" vaccines.…


Privacy Preference Center